|
楼主 |
发表于 2008-12-16 14:37:43
|
显示全部楼层
参考文献:. E0 M+ h; g+ o/ i( ?7 x
E C Keystone. Advances in targeted therapy: safety of biological agents. Ann Rheum Dis.,2003.(Supplfl):ii34一ii36
( ~% p! Y6 X5 }- H+ f) k9 Q Peter K. Gregersen, Richard Bucala. Macrophage Migretion Inhibitory Factor, MIF Allels, and the Genetics of Inflammatory Disorders: Incorporating Disease Outcome Into the Definition of Phenotype. Arthritis&Rheumatism, 2003.48(5):1171一1176 ) k1 u! |; M* F7 [
Cora Vizcarra. New Perspectives and Emerging Therpies for Immune-mediated inflammatory Disorders. Journal of InfusionNursing, 2003.26(5):319一325
* H5 [. f$ g4 i+ ?3 e4 g' X9 G ^! h Hiroaki Ito. IL-6 and Corhn' s disease. Current Drug Targets-inflammation&Allergy, 2003.2:125一130 7 S+ R# b O. {, D# ^- O _
Carol Dukes Hamilton. Tuberculosis in the Cytokine Era: Whgt Rheumatologists Need to Know. Arthritis&Rheumatism,2003.48(8):2085一2091 $ M5 ~6 f( A, D$ l) l
Gary S. Firestein. Evolving concepts of rheumatoid arthritis. Nature, 2003.423(15):356一361
g8 Y- @) M' m: l. q3 c2 I Peter K. K. Wong, Ian K. Campbell, Paul Jean et al. The Role of the Interleukin-6 Family of Cytokines in Inflammatory Arthritis and Bone Turnover. Arthritis& Rheumatism, 2003.48(5):1177一1189 9 y* D5 H: W: V- O% `3 m& e5 [
F Y Liew, X-Q Wei, I B Mclnnes. Role of interleukin 18 in rheumatoid arthritis. Ann Rheum Dis.,2003.62(SupplIj):ii48一550 2 s( I8 g0 n4 ^
I B Mclnnes, J A Gracie, M Harnett, F Y Liew. New strategies to control inflammatory synovitis: interleukin 15 and beyond. Ann Rheum Dis.,2003.62(Supp1II):ii51一ii54 # G8 V) n7 M! K
Krishna M. sundar, Marc V. Gosselin, et al. Emerging Concepts in Pathobiology, Radiology, and Clinical Evolution of disease. Pulmonary Langerhans Cell Histiocytosis. Chest, 2003.123:1673一1683
* P9 \) w5 b/ H* O PD Robbins, CH Evans, Y Chernajovsky. Gene therapy for arthristis. Gene Therapy, 2003.10:902一911 ' ]! ]! g' n E: U0 v- o; v9 Z+ R2 C
Tohru Abe, Tsutomu Takeuchi. Rheumatoid Arthritis and Tumor Necrosis Factor a. Autommunity, 2001.34:291一303 , J5 a5 v4 M/ A) D& ` Z3 |
Ernest H. S. Choy, Grbriel S. Panayi: Cytokine pathways and joint inflammatory in rheumatoid arthritis. Mechanisms of Disease. N Engl J Med, 2001.344(12):22
) q5 F; q7 S' q' W& `" k Leonardo Punzi, Lorenzo Calo, Mario Plebani. Clinical Significance of Cytokine Determination in Synovial Fluid. Critical Reviews in Clinical Laboratory Sciences, 2002. 39(1) :63一88
) o u3 Y1 X: ^; k$ e3 H% z Joseph C. Shanahan, E. William St. Clair. Tumor Necrosis Factor-a Blockade: A Novel Therapy for Rheumatic Disease. Clinical Immunology, 2002 ,103 (3) :231一242, Part 1 of 2 parts
7 k! g1 _% V( G; R: T Naoyuki Tsuchiya, Jun Ohashi, Katsushi Tokunaga. Variations in immune response genes and their associations with multifactorial immune disorders. Immunological Reviews, 2002.190:169一181
{$ S" b7 k+ E 成冰燕,王占元.细胞因子与类风湿关节炎治疗的研究进展.药学实践杂志,2000.18(3):143一144
$ N3 Q6 k: j1 i7 U8 A 王玉树.类风湿关节炎治疗靶点研究进展.国外医学预防、诊断、治疗用生物制品分册,2002.25(5):222一226
9 G/ T3 Q. L" j F Y Liew, I B McInnes. Role of interleukin 15 and interleukin 18 in inflammatory response. Ann Rheum Dis.,2002.61 (suppl 11) : ii 100一ii102
2 r0 ~8 j* J7 O! m5 d' f _; w 张信来,刘陶迪 类风湿关节炎与白细胞介素-1.生理科学进展,1999.30(3):252一254
5 Q1 _% L6 ?8 }+ T" L7 h! U+ } 费克香,雷元卫.类风湿关节炎免疫功能异常的研究进展.国外医学免疫学分册,1999.22(6):323一326 " x9 r' [* ]4 i1 v2 a3 m
Thomas Pap,Ulf Muller-Ladner. Renate Gay&Steffen Gay: Gene Therapy Promising For Rheumatoid Arthritis. Arthritis Res.,1999. 1(1):5一9
" y! T7 [) F) Y1 P: v Jean-Michel Dayer, Barry Bresnihan. Targeting Interleukin1 in the Treatment of Rheumatoid Arthritis. Arthritis & Rheumatism. 2002,46(3)574一578
4 E! z. r: d. w( u9 A 黄启阳,于孟学,姜玉娟,董怡.应用细胞因子及其拮抗剂治疗类风湿关节炎的进展.北京医学,1996.18(2):102一105 ) H( j. w; T" J5 i
Wim B van den Berg. Anti-cytokine therapy in chronic destructive arthritis. Arthritis Res.,2001.3:18一26
9 _0 y7 Q/ U( f( J: }( F, r Katsuhiko Ishihara, Toshio Hirano. IL-6 in autoimmune disease and chronic inflammatory prolixferative disease. Cytokine & Crowth Factor Reviews, 2002.13:357一368
* v* [+ ]( h. N( D Yoichiro Iwakura. Roles of IL-1 in the development of rheumatoid arthritis: consideration from mouse models. Cytokine & Crowth Factor Reviews, 2002.13:341一355 |
|